GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBD) » Definitions » ROC (Joel Greenblatt) %

cbdMD (YCBD) ROC (Joel Greenblatt) % : 42.59% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is cbdMD ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. cbdMD's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 42.59%.

The historical rank and industry rank for cbdMD's ROC (Joel Greenblatt) % or its related term are showing as below:

YCBD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -982.37   Med: -158.84   Max: 15.27
Current: -86.44

During the past 10 years, cbdMD's highest ROC (Joel Greenblatt) % was 15.27%. The lowest was -982.37%. And the median was -158.84%.

YCBD's ROC (Joel Greenblatt) % is ranked worse than
84.14% of 1015 companies
in the Drug Manufacturers industry
Industry Median: 9.34 vs YCBD: -86.44

cbdMD's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 15.70% per year.


cbdMD ROC (Joel Greenblatt) % Historical Data

The historical data trend for cbdMD's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

cbdMD ROC (Joel Greenblatt) % Chart

cbdMD Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -154.02 -187.53 -158.84 -110.16 -86.20

cbdMD Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -112.81 -69.54 -273.84 56.19 42.59

Competitive Comparison of cbdMD's ROC (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


cbdMD's ROC (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where cbdMD's ROC (Joel Greenblatt) % falls into.



cbdMD ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.916 + 3.226 + 0.752) - (6.157 + 0.55 + 0)
=-1.813

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.984 + 2.365 + 0.587) - (6.845 + 0.503 + 0)
=-3.412

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of cbdMD for the quarter that ended in Sep. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0.8/( ( (3.154 + max(-1.813, 0)) + (0.603 + max(-3.412, 0)) )/ 2 )
=0.8/( ( 3.154 + 0.603 )/ 2 )
=0.8/1.8785
=42.59 %

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


cbdMD  (AMEX:YCBD) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


cbdMD ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of cbdMD's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


cbdMD Business Description

Traded in Other Exchanges
Address
8845 Red Oak Boulevard, Charlotte, NC, USA, 28217
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Executives
Thomas Ronan Kennedy officer: Interim CEO and CFO 8845 RED OAK BLVD, CHARLOTTE NC 28217
Bakari T. Sellers director 4231 VOORHEES ROAD, DENMARK SC 29042
Raines William F Iii director 8314 TOSOMOCK LANE, HUNTERSVILLE NC 28078
Scott G. Stephen director 4249 NORTH WINCHESTER AVE., CHICAGO IL 60613
Sibyl Nichole Swift director 730 HAWTHORNE LANE, APT 441, CHARLOTTE NC 28204
Kevin Macdermott officer: President 9580 CALDWELL RD, MOUNT ULLA NC 28125
Wiesehan John J Iii officer: Chief Revenue Officer 8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Sim Farar director 8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Martin A. Sumichrast director, officer: Chairman of the Board and CEO 11125 COLONIAL COUNTRY LANE, CHARLOTTE NC 28277
Raymond Scott Coffman director 230 S. TRYON ST., #1302, CHARLOTTE NC 28202
Peter J. Ghiloni director 115 DEER ESTATES LANE, PONTE VEDRA BEACH FL 32082
Mark S Elliott officer: CFO & COO C/O LEVEL BRANDS, INC., 4521 SHARON ROAD, SUITE 450, CHARLOTTE NC 28211
Gregory C Morris director 421 CRANBORNE CHASE, FORT MILL SC 29708
Caryn Nicole Dunayer officer: President 8476 CATAWBA DOVE DR., BELMONT NC 28012
Erik Sterling 10 percent owner 5505 KALANIANAOLE HWY, HONOLULU HI 96821

cbdMD Headlines

From GuruFocus

Q2 2021 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q3 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

cbdMD Inc Extraordinary Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

Q2 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

cbdMD Stock Appears To Be Modestly Undervalued

By GF Value GF Value 05-16-2021

Q1 2024 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

cbdMD Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

Q4 2020 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024